Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 09-2006 | |
| Sales | 17,178 | 1,938 | 2,552 | 0 | 2,673 |
| Cost of Goods | 1,013 | 292 | 320 | N/A | 273 |
| Gross Profit | 16,165 | 1,646 | 2,232 | N/A | 2,400 |
| Operating Expenses | 114,115 | 81,544 | 44,952 | 0 | 29,578 |
| Operating Income | -97,937 | -79,606 | -42,400 | N/A | -26,905 |
| Other Income | 3,318 | 7,681 | 8,506 | 0 | 1,540 |
| Pre-tax Income | -94,619 | -71,925 | -33,894 | 0 | -25,365 |
| Income Tax | -1,268 | -278 | N/A | N/A | N/A |
| Net Income Continuous | -93,351 | -71,647 | -33,894 | N/A | -25,365 |
| Net Income | $-93,351 | $-71,647 | $-33,894 | $N/A | $-25,365 |
| EPS Basic Total Ops | -5.46 | -4.22 | -2.15 | N/A | -2.31 |
| EPS Basic Continuous Ops | -5.46 | -4.22 | -2.15 | N/A | -2.31 |
| EPS Diluted Total Ops | -5.46 | -4.22 | -2.15 | N/A | -2.31 |
| EPS Diluted Continuous Ops | -5.46 | -4.22 | -2.15 | N/A | -2.31 |
| EBITDA(a) | $-95,534 | $-77,627 | $-42,625 | $N/A | $-26,441 |